Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2001 1
2002 14
2003 17
2004 22
2005 20
2006 23
2007 27
2008 29
2009 48
2010 52
2011 70
2012 108
2013 119
2014 104
2015 97
2016 104
2017 128
2018 132
2019 144
2020 244
2021 231
2022 281
2023 309
2024 330
2025 365
2026 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,740 results

Results by year

Filters applied: . Clear all
Page 1
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.
Wu X, Sun Y, Yang H, Wang J, Lou H, Li D, Wang K, Zhang H, Wu T, Li Y, Wang C, Li G, Wang Y, Li D, Tang Y, Pan M, Cai H, Wang W, Yang B, Qian H, Tian Q, Yao D, Cheng Y, Wei B, Li X, Wang T, Hao M, Wang X, Wang T, Ran J, Zhu H, Zhu L, Liu X, Li Y, Chen L, Li Q, Yan X, Wang F, Cai H, Zhang Y, Liang Z, Liu F, Huang Y, Xia B, Qu P, Zhu G, Chen Y, Song K, Sun M, Chen Z, Zhou Q, Hu L, Abulizi G, Guo H, Liao S, Ye Y, Yan P, Tang Q, Sun G, Liu T, Lu D, Hu M, Wang ZM, Li B, Xia M. Wu X, et al. Among authors: huang y. Lancet. 2024 Oct 26;404(10463):1668-1676. doi: 10.1016/S0140-6736(24)02135-4. Epub 2024 Oct 16. Lancet. 2024. PMID: 39426385 Clinical Trial.
Consensus for antifungal stewardship in China (2024 edition).
Ye F, Cai S, Cao B, Cheng L, Fan H, Huang Y, Jiang S, Lai G, Li Y, Shi Y, She D, Su X, Tang K, Wang H, Wang L, Xu B, Xu J, Zhang J, Zhang J, Zhang T, Zhang W, Zhang Y, Zhou H, Hu J, Huang X, Jiang E, Liu Q, Wang J, Wu D, Zhang X, Kang Y, Qiu H, Gu B, Sun B, Xu Y, Cao C, Li R, Pan W, Zhuo C, Zhu L, Huang H, Tong R, Zhang J, Jiang M, Qu J. Ye F, et al. Among authors: huang y. J Thorac Dis. 2024 Jun 30;16(6):4016-4029. doi: 10.21037/jtd-24-13. Epub 2024 Jun 26. J Thorac Dis. 2024. PMID: 38983176 Free PMC article. Review.
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial.
Peng Z, Li H, Gao Y, Sun L, Jiang J, Xia B, Huang Y, Zhang Y, Xia Y, Zhang Y, Shen Y, Huang B, Nie J, Chen X, Liu X, Feng C, Li Z, Zhang W, Tao K, Zhang Q, Duan S, Chen Y, Chen Y, Wang W, Zheng H, Lu Y, Liu Y, Wang L, Qi W, He Y, Tian Y; NUWA Platform Research Group; Li G, Ma D, Gao Q. Peng Z, et al. Among authors: huang y. Lancet Oncol. 2024 Oct;25(10):1288-1297. doi: 10.1016/S1470-2045(24)00437-6. Epub 2024 Sep 11. Lancet Oncol. 2024. PMID: 39276785 Clinical Trial.
2,740 results